The pruritus of cholestasis and the opioid system.
Jones
E A
EA
Liver Diseases Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Md 20892.
Bergasa
N V
NV
D015209:Cholangitis, Sclerosing / Q000150:complications*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009270:Naloxone / Q000627:therapeutic use; D009271:Naltrexone / Q000031:analogs & derivatives / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use; D011537:Pruritus / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology*; D011957:Receptors, Opioid / Q000187:drug effects / Q000502:physiology*
D009292:Narcotic Antagonists; D011957:Receptors, Opioid; D009270:Naloxone; D009271:Naltrexone; C038981:nalmefene